Technology
Health
Pharmaceutical

Ovid Therapeutics

$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.13%) As of 12:19 PM EDT today
-$0.05 (-2.13%) Today

Why Robinhood?

You can buy or sell OVID and other stocks, options, ETFs, and crypto commission-free!

About OVID

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Employees
55
Headquarters
New York, New York
Founded
2014
Market Cap
90.93M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
274.75K
High Today
$2.38
Low Today
$2.28
Open Price
$2.37
Volume
65.36K
52 Week High
$11.02
52 Week Low
$1.53

Collections

Technology
Health
Pharmaceutical
Therapy
2017 IPO
US
North America

OVID Earnings

-$0.59
-$0.53
-$0.48
-$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.